Overview
Anna Nascimbeni practices in Paris, France. Ms. Nascimbeni is rated as an Advanced expert by MediFind in the treatment of Phosphoglycerate Mutase Deficiency. Her top areas of expertise are Pompe Disease, Phosphoglycerate Mutase Deficiency, Glutaric Acidemia Type 2, and Limb-Girdle Muscular Dystrophy.
Her clinical research consists of co-authoring 35 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Phosphoglycerate Mutase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Glutaric Acidemia Type 2Ms. Nascimbeni isAdvanced. Learn about Glutaric Acidemia Type 2.
- Phosphoglycerate Mutase DeficiencyMs. Nascimbeni isAdvanced. Learn about Phosphoglycerate Mutase Deficiency.
- Pompe DiseaseMs. Nascimbeni isAdvanced. Learn about Pompe Disease.
- Experienced
- Age-Related Macular Degeneration (ARMD)Ms. Nascimbeni isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Danon DiseaseMs. Nascimbeni isExperienced. Learn about Danon Disease.
- Late-Onset Retinal DegenerationMs. Nascimbeni isExperienced. Learn about Late-Onset Retinal Degeneration.
- Limb-Girdle Muscular DystrophyMs. Nascimbeni isExperienced. Learn about Limb-Girdle Muscular Dystrophy.
- Primary Carnitine DeficiencyMs. Nascimbeni isExperienced. Learn about Primary Carnitine Deficiency.